Clofazimine, an antimycobacterial with potent in vitro and in vivo leishmanicidal activity, is ineffective against cutaneous Leishmania major infection in humans

Journal of the American Academy of Dermatology

Volumn 62, Issue 5, 2010, Pages 890-892

  Namazi, Mohammad Reza ^a,b   Dastgheib, Ladan ^b   Mazandarani, Jaber ^b   Jowkar, Farideh ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; LEISHMANIA MAJOR; LEISHMANIASIS; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CLOFAZIMINE; FEMALE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 77950556552     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.07.011     Document Type: Article

References (6)

1. Alrajhi A.A., Ibrahim E.A., De Vol E.B., Khairat M., Faris R.M., and Maguire J.H. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346 (2002) 891-895
2. Reithinger R., Dujardin J.C., Louzir H., Primez C., Alexander B., and Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 7 (2007) 581-596
3. Evans A.T., Croft S.L., Peters W., and Neal R.A. Antilesihmanial effects of clofazimine and other antimycobacterial agents. Ann Trop Med Parasitol 83 (1989) 447-454
4. Datta G., and Bera T. The effect of clofazimine, niclosamide and amphotericin B, on electron transport of Leishmania donovani promastigotes. Indian J Med Res 112 (2000) 15-20
5. Torres Idavoy D., Montalvo Alvarez A.M., and Finlay C.M. Effects of clofazimine on Leishmania promastigotes. [in Spanish]. Rev Cubana Med Trop 39 (1987) 33-38
6. Knablo Jr. A.L., and Davis L.S. Miscellaneous systemic drugs. In: Wolverton S.E. (Ed). Comprehensive dermatologic drug therapy. 2nd ed (2007), Saunders Elsevier, China 475-477